MedTrace Logo

Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

NCT02145091 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-12-30

No results posted yet for this study

Summary

This is a double-blind placebo-controlled study investigating the acute and persisting effects of psilocybin on meditation, spirituality, health, well-being, prosocial attitudes, and brain functioning.

Conditions

  • Healthy

Interventions

DRUG

Moderately-high dose of psilocybin

Oral dose of a moderately-high dose of psilocybin.

DRUG

Moderately-low dose of psilocybin

Oral dose of a moderately-low dose of psilocybin.

DRUG

Very-low dose of psilocybin

Oral dose of a very-low dose of psilocybin.

DRUG

Placebo

An oral placebo (lactose pill).

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2019-12-26
Completion
2019-12-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02145091 on ClinicalTrials.gov